Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/EBIT

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 36.5437.63-0.150.25-0.25

What is the latest EV/EBIT ratio of MANKIND PHARMA ?

The latest EV/EBIT ratio of MANKIND PHARMA is 36.54 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202536.54
Mar202437.63
Mar2023-0.15
Mar20220.25
Mar2021-0.25

How is EV/EBIT of MANKIND PHARMA Trending?

Years EV/EBIT % Change
Mar2025 36.54
-2.90
Mar2024 37.63
Positive
Mar2023 -0.15
Negative
Mar2022 0.25
Positive
Mar2021 -0.25 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/EBIT ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹89,249.4 Cr -2.7% 4.6% -2.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,704.0 Cr 3.5% 5.6% 11.9% Stock Analytics
DIVIS LABORATORIES ₹168,223.0 Cr -1.3% 4.5% 16.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,928.0 Cr -0.7% 6.9% 47.8% Stock Analytics
DR REDDYS LABORATORIES ₹107,368.0 Cr 1.3% 5.1% 17.5% Stock Analytics
CIPLA ₹107,043.0 Cr -1.9% -0.3% -6% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-2.7%

4.6%

-2.8%

SENSEX

-4.6%

-7.5%

6%


You may also like the below Video Courses